2022
DOI: 10.1007/s00439-022-02457-6
|View full text |Cite
|
Sign up to set email alerts
|

Genome interpretation using in silico predictors of variant impact

Abstract: Estimating the effects of variants found in disease driver genes opens the door to personalized therapeutic opportunities. Clinical associations and laboratory experiments can only characterize a tiny fraction of all the available variants, leaving the majority as variants of unknown significance (VUS). In silico methods bridge this gap by providing instant estimates on a large scale, most often based on the numerous genetic differences between species. Despite concerns that these methods may lack reliability … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
33
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(33 citation statements)
references
References 374 publications
(456 reference statements)
0
33
0
Order By: Relevance
“…While a plethora of in silico prediction algorithms of variant impact are available and useful for assessment of great numbers of uncharacterized variants [ 29 ], clinical decision making is still based on additional markers of pathogenicity or neutrality. The International Society for Gastrointestinal Hereditary Tumours (InSiGHT) has developed criteria for the interpretation of MMR gene variants.…”
Section: Introductionmentioning
confidence: 99%
“…While a plethora of in silico prediction algorithms of variant impact are available and useful for assessment of great numbers of uncharacterized variants [ 29 ], clinical decision making is still based on additional markers of pathogenicity or neutrality. The International Society for Gastrointestinal Hereditary Tumours (InSiGHT) has developed criteria for the interpretation of MMR gene variants.…”
Section: Introductionmentioning
confidence: 99%
“…Databases can be categorized according to their scope, purpose, and scale. Several reviews ( Thorisson et al, 2009 ; Brookes and Robinson, 2015 ; Zhang et al, 2019 ; Banck et al, 2021 ; Katsonis et al, 2022 ) provided comprehensive details of the content, usage, comparisons, and limitations for those databases. In this section, we briefly review the most frequently used databases ( Table 1 ) containing sequence information, population-scale data, phenotype ontology, clinical and experimental evidence.…”
Section: Database Resources For Variant Predictorsmentioning
confidence: 99%
“…Advances in technologies for whole-genome or exome sequencing and high-throughput functional assays have increased our knowledge on the consequences of the genetic variability in humans and the relationship to disease ( McInnes et al, 2021 ; Arnedo-Pac et al, 2022 ; Høie et al, 2022 ; Katsonis et al, 2022 ). However, our capacity to predict the pathogenicity of single amino acid variants is still limited, with some approaches providing good overall results but failing to predict correlation for some individual mutations or phenotypes ( Katsonis et al, 2022 ).…”
Section: Introductionmentioning
confidence: 99%